Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.060
+0.170 (5.88%)
At close: Apr 28, 2026, 4:00 PM EDT
3.070
+0.010 (0.33%)
After-hours: Apr 28, 2026, 7:32 PM EDT
Editas Medicine Employees
Editas Medicine had 87 employees as of December 31, 2025. The number of employees decreased by 159 or -64.63% compared to the previous year.
Employees
87
Change (1Y)
-159
Growth (1Y)
-64.63%
Revenue / Employee
$465,747
Profits / Employee
-$1,839,770
Market Cap
299.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| LENZ Therapeutics | 152 |
| Coherus Oncology | 147 |
| AC Immune | 122 |
| Zentalis Pharmaceuticals | 106 |
| C4 Therapeutics | 104 |
| Compugen | 75 |
| Cybin | 50 |
EDIT News
- 1 day ago - Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences - GlobeNewsWire
- 4 weeks ago - Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference - GlobeNewsWire
- 6 weeks ago - Editas Medicine Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates - GlobeNewsWire
- 2 months ago - Editas Medicine Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Editas Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Genflow Biosciences PLC Announces Directorate Change - Accesswire
- 5 months ago - Editas Medicine Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts